Immatics N.V.
NASDAQ:IMTXBiotechnology
+$0.15 today
- Market cap
- $912.78M
- Beta
- 1.30
- P/E (TTM)
- -5.3
- EPS (TTM)
- -$1.59
Volume 1.57M
Average 0.46M
IMTX Net Margin
Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.
Immatics N.V.NASDAQ: IMTX
Net Margin · Q1 FY2026 · quarter ended Mar 2026
Net margin narrows to -759.5%
Net margin was -759.5% in Q1 FY2026, down 545.0 pp from a year earlier. On a trailing-twelve-month basis it was -574.9%, down 559.9 pp year over year. Over 3 fiscal years it narrowed by 428.7 pp.
Context
- Net margin widened in 1 of the last 3 fiscal years.
- FY2025 was the lowest level in the 4 fiscal years shown.
What to watch
Whether net margin reaches the consensus estimate from 4 analysts of -685.9% for the fiscal year ending Dec 2026, down from -407.0% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -759.5%-578.9 pp QoQ
- Last fiscal yearDec 2025
- -407.0%-416.8 pp YoY
- LTMMar 2026
- -574.9%-559.9 pp YoY
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- -407.0%
- Year-over-year change
- -416.8pp
| Period | Period end | Net Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | -407.0% | -416.8pp |
| FY2024 | 2024-12-31 | 9.8% | +189.4pp |
| FY2023 | 2023-12-31 | -179.6% | -201.3pp |
| FY2022 | 2022-12-31 | 21.7% | +295.2pp |
| FY2021 | 2021-12-31 | -273.5% | — |
Net Margin vs competitors
How IMTX compares with its peers on the latest reported figures
- IMTX's LTM Mar 2026 net margin of -574.9% is the 8th highest of the 10 companies compared; the peer median is -98.7%.
- Its year-over-year change of -559.9 pp is the 9th highest of 10, against a peer median of +1.6 pp.
- Over three fiscal years its change of -428.7 pp compares with a peer median of +21.3 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Sep 2026 | -0.0% | +26.4 pp | +352.6 pp | |
| LTM Mar 2026 | -4.9% | +1.6 pp | +21.3 pp | |
| LTM Mar 2026 | -40.9% | -33.1 pp | +386.2 pp | |
| LTM Jun 2026 | -64.0% | -52.0 pp | -94.1 pp | |
| LTM Mar 2026 | -98.7% | -55.7 pp | +308.8 pp | |
| LTM Mar 2026 | -98.8% | +28.3 pp | +461.0 pp | |
| LTM Mar 2026 | -529.7% | +303.0 pp | -404.0 pp | |
| LTM Mar 2026 | -574.9% | -559.9 pp | -428.7 pp | |
| LTM Mar 2026 | -1360.6% | +1613.5 pp | -767.6 pp | |
| LTM Mar 2026 | -794858.1% | -280208.8 pp | -762139.3 pp | |
| FY2025 | — | — | — | |
| Peer median (excluding IMTX) | -98.7% | +1.6 pp | +21.3 pp | |
Competitors are the stored peer set for IMTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 34.76M | 172.83M | 54M | 155.84M | 48.27M |
| Cost of Revenue | 87.57M | 106.78M | 118.66M | 0 | 0 |
| Gross Profit | (52.81M) | 66.05M | (64.67M) | 155.84M | 48.27M |
| Gross Margin | -151.9% | 38.2% | -119.8% | 100.0% | 100.0% |
| Research & Development | 87.57M | 106.78M | 118.66M | 148.08M | 183.83M |
| Selling, General & Admin | 33.81M | 36.12M | 38.2M | 46.45M | 51.18M |
| Operating Expenses | 121.05M | 142.88M | 155.72M | 194.45M | 230.28M |
| Depreciation & Amortization | 5.47M | 6.84M | 7.23M | 12.23M | 12.4M |
| EBITDA | (87.3M) | 50.04M | (88.93M) | 34.46M | (185.09M) |
| EBITDA Margin | -251.1% | 29.0% | -164.7% | 22.1% | -383.5% |
| Operating Income | (86.29M) | 29.95M | (101.73M) | (38.62M) | (182.02M) |
| Operating Margin | -248.2% | 17.3% | -188.4% | -24.8% | -377.1% |
| Interest Income | 133K | 2.48M | 13.85M | 25M | 17.18M |
| Interest Expense | 566K | 1.04M | 831K | 886K | 946K |
| Other Income / Expenses | (7.04M) | 12.08M | 4.73M | 59.96M | (16.42M) |
| Income Before Tax | (93.34M) | 42.04M | (96.99M) | 21.35M | (198.44M) |
| Pre-Tax Margin | -268.5% | 24.3% | -179.6% | 13.7% | -411.1% |
| Income Tax Expense | 0 | 4.55M | 0 | 6.13M | (1.99M) |
| Net Income | (95.06M) | 37.51M | (96.99M) | 15.22M | (196.45M) |
| Net Margin | -273.5% | 21.7% | -179.6% | 9.8% | -407.0% |
| EPS (Basic) | (1.51) | 0.55 | (1.20) | 0.14 | (1.54) |
| EPS (Diluted) | (1.51) | 0.54 | (1.20) | 0.14 | (1.54) |
| Weighted Avg Shares | 62.91M | 67.22M | 80.55M | 108.7M | 122.35M |
| Weighted Avg Shares (Diluted) | 62.91M | 68.82M | 80.55M | 106.8M | 122.35M |
Immatics N.V.
NASDAQ:IMTX
Intrinsic Alpha fair value
Locked
Current Price
$6.10
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.